Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine

BACKGROUND: Pancreatic cancer is a common, highly lethal disease with a rising incidence. MUC1 is a tumor-associated antigen that is over-expressed in pancreatic adenocarcinoma. Active immunotherapy that targets MUC1 could have great treatment value. Here we investigated the preventive and therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Yefei, Jin, Dayong, Wu, Wenchuan, Lou, Wenhui, Wang, Danshong, Kuang, Tiantao, Ni, Xiaoling, Qin, Xinyu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702393/
https://www.ncbi.nlm.nih.gov/pubmed/19534821
http://dx.doi.org/10.1186/1471-2407-9-191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702393/
https://www.ncbi.nlm.nih.gov/pubmed/19534821
http://dx.doi.org/10.1186/1471-2407-9-191

Ejemplares similares